- News Releases
Last week, the Food and Drug Administration paved the way for commercial developers to create at-home COVID-19 tests. While no test is yet approved for home use, a fast and cheap test could encourage people to test themselves routinely before going to work or school. Real-time results would enable infected people to self-quarantine right away, keeping asymptomatic people from infecting others. "It fits with the modeling that’s been done where if you can test frequently enough that you could actually start to dampen down, if people would quarantine, you could dampen down cases. And that, as you know, would be huge," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group.
On the Mayo Clinic Q&A podcast, Dr. Poland discusses the science behind at-home testing for COVID-19. Dr. Poland also shares the status of vaccine research trials, including how healthy adults can enroll in the COVID-19 vaccine clinical trial.
Research disclosures for Dr. Gregory Poland.
Mayo Clinic Q&A is available on podcast platforms including Apple, Google, Spotify, Stitcher, TuneIn and iHeart.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding along with guidelines and recommendations may have changed since the original publication date.
Check the CDC website for additional updates on COVID-19. For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.
To simplify COVID-19 vaccine administration, the Food and Drug Administration ended the use of the original monovalent COVID-19 vaccines on April 18. People who are due for the bivalent vaccine ...
Like many people throughout the world, Matthew Binnicker, Ph.D., remembers exactly where he was and what he was doing when COVID-19 was classified as a pandemic. ...
While COVID-19 rates in the U.S. are relatively low and are declining, the World Health Organization (WHO) is keeping an eye on a new COVID-19 ...